Celleron Therapeutics company

Celleron is building a global oncology company focussed on the clinical development of new and innovative therapies to treat cancer. Celleron’s vision is that the future of cancer therapy lies in the ability to match patients to treatments that are tailored to their tumours – effectively selecting the right drug, at the right dose, for the right patient.
Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The Company’s lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified.
Technology: P4 Medicine
Industry: Preventive Medicine
Headquarters: Abingdon, Oxfordshire, United Kingdom
Founded Date: 2005
Employees Number: Undisclosed
Funding Status: N/A
Investors Number: 4
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership